Advanced Search


Study ID Status Title Patient Level Data
204926 Active, not recruiting Long term immunogenicity and safety study of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A and assessment of re-vaccination with 2 additional doses, in healthy subjects aged 60 years of age and older Study Listed on
204927 Completed PGx7643: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL112341
204928 Completed Study to evaluate the impact of reactogenicity on Quality of Life (QoL), after administration of GSK Biologicals’ candidate Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A) in adults ≥ 50 years of age
204930 Completed Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity with a Daily Use Anti-Sensitivity Toothpaste
204943 Not yet recruiting PRJ2568: Comparing durability, treatment failure and emergence of resistance of integrase strand transfer inhibitor treatment regimens among treatment-naïve and treatment-experienced patients with HIV
204946 Completed A single center, two part, randomized, open label cross-over study to evaluate the effect of itraconazole and rifampicin on the pharmacokinetics of GSK525762 in healthy female subjects of non child bearing potential
204947 Active, not recruiting A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with overactive bladder
204948 Active, not recruiting A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with urinary incontinence due to neurogenic detrusor overactivity
204953 Completed A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Continuation Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 with Ritonavir, in Healthy Subjects
204957 Terminated A randomised, multi-center, double blind (sponsor open), placebo-controlled study to assess the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of GSK3117391 in subjects with severe, active rheumatoid arthritis
204958 Completed An open label, randomised, three arm, single dose, multicentre, parallel group study in healthy subjects to compare the pharmacokinetics of subcutaneous mepolizumab when delivered as a liquid drug product in a safety syringe or an auto injector with a reconstituted lyophilised drug product from a vial
204959 Completed An open-label, single arm, repeat dose, multi-centre study to evaluate the use of an autoinjector for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study 204959)
204979 Completed A Single-Dose, Open-Label, Three-way Crossover Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and one Reference) in Chinese Male Healthy Adult Smokers
204980 Completed 204980: An open-label study to evaluate the correct use of placebo ELLIPTA™ dry powder inhaler (DPI) compared to placebo metered dose inhalers (MDI) in subjects with moderate persistent asthma
204981 Completed An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD)
204983 Completed An open-label study to evaluate the preference attributes of the ELLIPTA™ dry powder inhaler (DPI) compared to the HandiHaler™ DPI in subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
204987 Recruiting The effects of GSK2586881 on the responses to acute hypoxia and exercise
204990 Completed A Randomized, Open-Label, 8-Week Cross-Over Study to Compare Umeclidinium/Vilanterol with Tiotropium/Olodaterol Once-Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
204999 Terminated Comparative Effectiveness of Belimumab Use among SLE Patients in a Commercially Insured US Population: 2010-2014
205012 Withdrawn A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in Subjects with Polymyalgia Rheumatica
205017 Recruiting A two part, non-randomized, open label study designed to assess the pharmacokinetics of GSK2982772 following administration of modified release formulations in capsule relative to an immediate release reference tablet formulation (Part A) and the pharmacokinetics of escalating, repeat doses of a selected modified release prototype (Part B) in healthy subjects
205021 Recruiting A single-centre, randomized, double-blind (sponsor open), placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2983559, in single (in both fed and fasted states) and repeat oral doses in healthy participants
205024 Completed Skin Acceptability Assessment of 874A in subjects with sensitive skin Under Normal Usage Conditions
205033 Completed A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects after Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.